Bicalutamide + Goserelin
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Bicalutamide
bicalutamide - Goserelin
goserelin
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| goserelin + bicalutamideAU | 3.6 mg / 50 mg / 10.8 mg | AstraZeneca Pty Ltd |
| ZolaCos CP Combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister packAU | 50 mg / 3.6 mg / 10.8 mg | AstraZeneca Pty Ltd |
| ZolaCos CP 3.6/50AU | 3.6 mg / 50 mg | AstraZeneca Pty Ltd |
| ZolaCos CP 10.8/50(28)AU | 10.8 mg / 50 mg | AstraZeneca Pty Ltd |
| ZolaCos CP 10.8/50(84)AU | 10.8 mg / 50 mg | AstraZeneca Pty Ltd |
| ZolaCos CPAU | — | — |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.